{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:02:48Z","timestamp":1762254168467},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00508-022-02040-z","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T16:23:14Z","timestamp":1652804594000},"page":"636-645","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease"],"prefix":"10.1007","volume":"134","author":[{"given":"Ivan","family":"Velat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017deljko","family":"Bu\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"\u010culi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster\u00a0AC, Nagler\u00a0EV, Morton\u00a0RL, Masson\u00a0P. Chronic kidney disease. Lancet. 2017;389:1238\u201352.","journal-title":"Lancet"},{"key":"2040_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen\u00a0TK, Knicely\u00a0DH, Grams\u00a0ME. Chronic kidney disease diagnosis and management: a\u00a0review. JAMA. 2019;322:1294\u2013304.","journal-title":"JAMA"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99:S1\u2013S87.","journal-title":"Kidney Int"},{"key":"2040_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/ndt\/gfv427","volume":"31","author":"L De Nicola","year":"2016","unstructured":"De Nicola\u00a0L, Zoccali\u00a0C. Chronic kidney disease prevalence in the general population: heterogeneity and concerns. Nephrol Dial Transplant. 2016;31:331\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"2040_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000362458","volume":"128","author":"M Tonelli","year":"2014","unstructured":"Tonelli\u00a0M, Riella\u00a0M. Chronic kidney disease and the ageing population. Nephron Clin Pract. 2014;128:319\u201322.","journal-title":"Nephron Clin Pract"},{"key":"2040_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000452725","volume":"43","author":"T Dhondup","year":"2017","unstructured":"Dhondup\u00a0T, Qian\u00a0Q. Electrolyte and acid-base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif. 2017;43:179\u201388.","journal-title":"Blood Purif"},{"key":"2040_CR7","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.cjca.2019.04.002","volume":"35","author":"H Yogasundaram","year":"2019","unstructured":"Yogasundaram\u00a0H, Chappell\u00a0MC, Braam\u00a0B, Oudit\u00a0GY. Cardiorenal syndrome and heart failure-challenges and opportunities. Can J Cardiol. 2019;35:1208\u201319.","journal-title":"Can J Cardiol"},{"key":"2040_CR8","first-page":"1204","volume":"32","author":"H Huang","year":"2017","unstructured":"Huang\u00a0H, Jolly\u00a0SE, Airy\u00a0M, et\u00a0al. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017;32:1204\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"2040_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.5301\/JN.2011.6410","volume":"24","author":"D Adams","year":"2011","unstructured":"Adams\u00a0D, de Jonge\u00a0R, van der Cammen\u00a0T, Zietse\u00a0R, Hoorn\u00a0EJ. Acute kidney injury in patients presenting with hyponatremia. J\u00a0Nephrol. 2011;24:749\u201355.","journal-title":"J Nephrol"},{"key":"2040_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2012.246","volume":"9","author":"RW Schrier","year":"2013","unstructured":"Schrier\u00a0RW, Sharma\u00a0S, Shchekochikhin\u00a0D. Hyponatraemia: more than just a\u00a0marker of disease severity? Nat Rev Nephrol. 2013;9:37\u201350.","journal-title":"Nat Rev Nephrol"},{"key":"2040_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","volume":"126","author":"G Liamis","year":"2013","unstructured":"Liamis\u00a0G, Rodenburg\u00a0EM, Hofman\u00a0A, Zietse\u00a0R, Stricker\u00a0BH, Hoorn\u00a0EJ. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013;126:256\u201363.","journal-title":"Am J Med"},{"key":"2040_CR12","doi-asserted-by":"publisher","first-page":"15949","DOI":"10.1038\/s41598-017-16242-3","volume":"7","author":"L Sun","year":"2017","unstructured":"Sun\u00a0L, Hou\u00a0Y, Xiao\u00a0Q, Du\u00a0Y. Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: a meta-analysis and systematic review. Sci Rep. 2017;7:15949.","journal-title":"Sci Rep"},{"key":"2040_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000493246","volume":"52","author":"G Liamis","year":"2019","unstructured":"Liamis\u00a0G, Megapanou\u00a0E, Elisaf\u00a0M, Milionis\u00a0H. Hyponatremia-inducing drugs. Front Horm Res. 2019;52:167\u201377.","journal-title":"Front Horm Res"},{"key":"2040_CR14","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang\u00a0X, Cheng\u00a0Z. Cross-sectional studies: strengths, weaknesses, and recommendations. Chest. 2020;158:S65\u201371.","journal-title":"Chest"},{"key":"2040_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/fca.15.56","volume":"11","author":"RJ Mentz","year":"2015","unstructured":"Mentz\u00a0RJ, Velazquez\u00a0EJ, Metra\u00a0M, et\u00a0al. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. Future Cardiol. 2015;11:585\u201395.","journal-title":"Future Cardiol"},{"key":"2040_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.4065\/80.12.1623","volume":"80","author":"WH Tang","year":"2005","unstructured":"Tang\u00a0WH, Parameswaran\u00a0AC, Maroo\u00a0AP, Francis\u00a0GS. Aldosterone receptor antagonists in the medical management of chronic heart failure. Mayo Clin Proc. 2005;80:1623\u201330.","journal-title":"Mayo Clin Proc"},{"key":"2040_CR17","first-page":"147","volume":"10","author":"SA Lava","year":"2017","unstructured":"Lava\u00a0SA, Bianchetti\u00a0MG, Milani\u00a0GP. Testing Na+ in blood. Clin Kidney\u00a0J. 2017;10:147\u20138.","journal-title":"Clin Kidney J"},{"key":"2040_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","volume":"342","author":"HJ Adrogu\u00e9","year":"2000","unstructured":"Adrogu\u00e9\u00a0HJ, Madias\u00a0NE. Hyponatremia. N\u00a0Engl J Med. 2000;342:1581\u20139.","journal-title":"N Engl J Med"},{"key":"2040_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey\u00a0AS, Bosch\u00a0JP, Lewis\u00a0JB, Greene\u00a0T, Rogers\u00a0N, Roth\u00a0D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a\u00a0new prediction equation. Modification of Diet in Renal Disease Study group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"2040_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/00041552-200111000-00009","volume":"10","author":"G Manjunath","year":"2001","unstructured":"Manjunath\u00a0G, Sarnak\u00a0MJ, Levey\u00a0AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens. 2001;10:785\u201392.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2040_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","volume":"170","author":"R Wald","year":"2010","unstructured":"Wald\u00a0R, Jaber\u00a0BL, Price\u00a0LL, Upadhyay\u00a0A, Madias\u00a0NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170:294\u2013302.","journal-title":"Arch Intern Med"},{"key":"2040_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","volume":"28","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade\u00a0M, Abraham\u00a0WT, Albert\u00a0NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart\u00a0J. 2007;28:980\u20138.","journal-title":"Eur Heart J"},{"key":"2040_CR23","doi-asserted-by":"publisher","first-page":"e3898","DOI":"10.1097\/MD.0000000000003898","volume":"95","author":"JJ Park","year":"2016","unstructured":"Park\u00a0JJ, Chae\u00a0IH, Choi\u00a0DJ, et\u00a0al. Renal function, serum sodium level, and outcomes in hospitalized systolic heart failure patients: an analysis of the COAST study. Medicine. 2016;95:e3898.","journal-title":"Medicine"},{"key":"2040_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10741-015-9482-y","volume":"20","author":"C Urso","year":"2015","unstructured":"Urso\u00a0C, Brucculeri\u00a0S, Caimi\u00a0G. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev. 2015;20:493\u2013503.","journal-title":"Heart Fail Rev"},{"key":"2040_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jacc.2014.12.010","volume":"65","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge\u00a0FH, Steels\u00a0P, Grieten\u00a0L, Nijst\u00a0P, Tang\u00a0WH, Mullens\u00a0W. Hyponatremia in acute decompensated heart failure: depletion versus dilution. J\u00a0Am Coll Cardiol. 2015;65:480\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"2040_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40360-020-00431-4","volume":"21","author":"I Velat","year":"2020","unstructured":"Velat\u00a0I, Bu\u0161i\u0107 \u017d, Juri\u0107 Pai\u0107\u00a0M, \u010culi\u0107\u00a0V. Furosemide and spironolactone doses and hyponatremia in patients with heart failure. BMC Pharmacol Toxicol. 2020;21:57.","journal-title":"BMC Pharmacol Toxicol"},{"key":"2040_CR27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/eurjhf\/hfs115","volume":"14","author":"N Deubner","year":"2012","unstructured":"Deubner\u00a0N, Berliner\u00a0D, Frey\u00a0A, et\u00a0al. Dysnatraemia in heart failure. Eur J Heart Fail. 2012;14:1147\u201354.","journal-title":"Eur J Heart Fail"},{"key":"2040_CR28","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.amjcard.2014.03.017","volume":"113","author":"C Bavishi","year":"2014","unstructured":"Bavishi\u00a0C, Ather\u00a0S, Bambhroliya\u00a0A, et\u00a0al. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014;113:1834\u20138.","journal-title":"Am J Cardiol"},{"key":"2040_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1517\/14656566.2014.879118","volume":"15","author":"J Tamargo","year":"2014","unstructured":"Tamargo\u00a0J, Segura\u00a0J, Ruilope\u00a0LM. Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics. Expert Opin Pharmacother. 2014;15:527\u201347.","journal-title":"Expert Opin Pharmacother"},{"key":"2040_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1517\/14656566.2014.879117","volume":"15","author":"J Tamargo","year":"2014","unstructured":"Tamargo\u00a0J, Segura\u00a0J, Ruilope\u00a0LM. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents. Expert Opin Pharmacother. 2014;15:605\u201321.","journal-title":"Expert Opin Pharmacother"},{"key":"2040_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy\u00a0CW, Jessup\u00a0M, Bozkurt\u00a0B, et\u00a0al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. J\u00a0Am Coll Cardiol. 2017;70:776\u2013803.","journal-title":"J Am Coll Cardiol"},{"key":"2040_CR32","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt\u00a0B, Pfeffer\u00a0MA, Assmann\u00a0SF, et\u00a0al. Spironolactone for heart failure with preserved ejection fraction. N\u00a0Engl J Med. 2014;370:1383\u201392.","journal-title":"N Engl J Med"},{"key":"2040_CR33","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/ejhf.1909","volume":"22","author":"JP Ferreira","year":"2020","unstructured":"Ferreira\u00a0JP, Rossello\u00a0X, Pocock\u00a0SJ, et\u00a0al. Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT. Eur J Heart Fail. 2020;22:1615\u201324.","journal-title":"Eur J Heart Fail"},{"key":"2040_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ejhf.2031","volume":"23","author":"V \u010culi\u0107","year":"2020","unstructured":"\u010culi\u0107\u00a0V, Velat\u00a0I. Spironolactone discontinuation in patients with heart failure: complex interactions with loop diuretics. Letter regarding the article \u2018Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT. Eur J Heart Fail. 2020;23:198\u20139.","journal-title":"Eur J Heart Fail"},{"key":"2040_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jchf.2014.05.014","volume":"2","author":"PM McKie","year":"2014","unstructured":"McKie\u00a0PM, Schirger\u00a0JA, Benike\u00a0SL, Harstad\u00a0LK, Chen\u00a0HH. The effects of dose reduction of furosemide on glomerular filtration rate in stable systolic heart failure. JACC Heart Fail. 2014;2:675\u20137.","journal-title":"JACC Heart Fail"},{"key":"2040_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ijcard.2014.09.156","volume":"177","author":"CJ Kapelios","year":"2014","unstructured":"Kapelios\u00a0CJ, Kaldara\u00a0E, Ntalianis\u00a0A, et\u00a0al. Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a\u00a0randomized study. Int J Cardiol. 2014;177:690\u20132.","journal-title":"Int J Cardiol"},{"key":"2040_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000447068","volume":"133","author":"A Ahmed","year":"2016","unstructured":"Ahmed\u00a0A, Jorna\u00a0T, Bhandari\u00a0S. Should we STOP angiotensin converting enzyme inhibitors\/angiotensin receptor blockers in advanced kidney disease? Nephron. 2016;133:147\u201358.","journal-title":"Nephron"},{"key":"2040_CR38","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2174\/1381612811319170009","volume":"19","author":"H Kobori","year":"2013","unstructured":"Kobori\u00a0H, Mori\u00a0H, Masaki\u00a0T, Nishiyama\u00a0A. Angiotensin II blockade and renal protection. Curr Pharm Des. 2013;19:3033\u201342.","journal-title":"Curr Pharm Des"},{"key":"2040_CR39","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray\u00a0JJ, Adamopoulos\u00a0S, Anker\u00a0SD, et\u00a0al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart\u00a0J. 2012of;33:1787\u2013847.","journal-title":"Eur Heart J"},{"key":"2040_CR40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1681\/ASN.2020050682","volume":"32","author":"EL Fu","year":"2021","unstructured":"Fu\u00a0EL, Evans\u00a0M, Clase\u00a0CM, et al. Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a\u00a0nationwide study. J\u00a0Am Soc Nephrol. 2021;32:424\u201335.","journal-title":"J Am Soc Nephrol"},{"key":"2040_CR41","doi-asserted-by":"publisher","first-page":"e3696","DOI":"10.1210\/clinem\/dgaa194","volume":"105","author":"H Falhammar","year":"2020","unstructured":"Falhammar\u00a0H, Skov\u00a0J, Calissendorff\u00a0J, Nathanson\u00a0D, Lindh\u00a0JD, Mannheimer\u00a0B. Associations between antihypertensive medications and severe hyponatremia: a\u00a0swedish population-based case-control study. J\u00a0Clin Endocrinol Metab. 2020;105:e3696\u2013e705.","journal-title":"J Clin Endocrinol Metab"},{"key":"2040_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/0976-500X.171880","volume":"6","author":"S Das","year":"2015","unstructured":"Das\u00a0S, Bandyopadhyay\u00a0S, Ramasamy\u00a0A, Prabhu\u00a0VV, Pachiappan\u00a0S. A case of losartan-induced severe hyponatremia. J\u00a0Pharmacol Pharmacother. 2015;6:219\u201321.","journal-title":"J Pharmacol Pharmacother"},{"key":"2040_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.me.41.020190.001445","volume":"41","author":"L Chan","year":"1990","unstructured":"Chan\u00a0L, Schrier\u00a0RW. Effects of calcium channel blockers on renal function. Annu Rev Med. 1990;41:289\u2013302.","journal-title":"Annu Rev Med"},{"key":"2040_CR44","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/archinte.1992.00400200011003","volume":"152","author":"M Epstein","year":"1992","unstructured":"Epstein\u00a0M. Calcium antagonists and renal protection. Current status and future perspectives. Arch Intern Med. 1992;152:1573\u201384.","journal-title":"Arch Intern Med"},{"key":"2040_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","volume":"356","author":"MJ Brown","year":"2000","unstructured":"Brown\u00a0MJ, Palmer\u00a0CR, Castaigne\u00a0A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a\u00a0long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a\u00a0Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366\u201372.","journal-title":"Lancet"},{"key":"2040_CR46","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981\u201397.","journal-title":"JAMA"},{"key":"2040_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1751-7176.2008.08126.x","volume":"10","author":"SJ Mann","year":"2008","unstructured":"Mann\u00a0SJ. The silent epidemic of thiazide-induced hyponatremia. J\u00a0Clin Hypertens. 2008;10:477\u201384.","journal-title":"J Clin Hypertens"},{"key":"2040_CR48","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/archinte.1995.00430090099011","volume":"155","author":"EL Siegler","year":"1995","unstructured":"Siegler\u00a0EL, Tamres\u00a0D, Berlin\u00a0JA, Allen-Taylor\u00a0L, Strom\u00a0BL. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med. 1995;155:953\u20137.","journal-title":"Arch Intern Med"},{"key":"2040_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/dme.13564","volume":"35","author":"PH Winocour","year":"2018","unstructured":"Winocour\u00a0PH. Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a\u00a0paradigm shift in care. Diabet Med. 2018;35:300\u20135.","journal-title":"Diabet Med"},{"key":"2040_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13098-019-0403-4","volume":"11","author":"MK Sulaiman","year":"2019","unstructured":"Sulaiman\u00a0MK. Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management. Diabetol Metab Syndr. 2019;11:7.","journal-title":"Diabetol Metab Syndr"},{"key":"2040_CR51","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1056\/NEJMra1503102","volume":"373","author":"BF Palmer","year":"2015","unstructured":"Palmer\u00a0BF, Clegg\u00a0DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N\u00a0Engl J Med. 2015;373:548\u201359.","journal-title":"N Engl J Med"},{"key":"2040_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.12998\/wjcc.v2.i10.488","volume":"2","author":"G Liamis","year":"2014","unstructured":"Liamis\u00a0G, Liberopoulos\u00a0E, Barkas\u00a0F, Elisaf\u00a0M. Diabetes mellitus and electrolyte disorders. World J Clin Cases. 2014;2:488\u201396.","journal-title":"World J Clin Cases"},{"key":"2040_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000481209","volume":"46","author":"AK Leonberg-Yoo","year":"2017","unstructured":"Leonberg-Yoo\u00a0AK, Rudnick\u00a0MR. Tobacco use: a\u00a0chronic kidney disease accelerant. Am J Nephrol. 2017;46:257\u20139.","journal-title":"Am J Nephrol"},{"key":"2040_CR54","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/ki.1997.232","volume":"51","author":"SR Orth","year":"1997","unstructured":"Orth\u00a0SR, Ritz\u00a0E, Schrier\u00a0RW. The renal risks of smoking. Kidney Int. 1997;51:1669\u201377.","journal-title":"Kidney Int"},{"key":"2040_CR55","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMra1704724","volume":"377","author":"BF Palmer","year":"2017","unstructured":"Palmer\u00a0BF, Clegg\u00a0DJ. Electrolyte disturbances in patients with chronic alcohol-use disorder. N\u00a0Engl J Med. 2017;377:1368\u201377.","journal-title":"N Engl J Med"},{"key":"2040_CR56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.amjmed.2013.07.021","volume":"126","author":"S Mohan","year":"2013","unstructured":"Mohan\u00a0S, Gu\u00a0S, Parikh\u00a0A, Radhakrishnan\u00a0J. Prevalence of hyponatremia and association with mortality: results from NHANES. Am J Med. 2013;126:1127\u20131137.e1.","journal-title":"Am J Med"},{"key":"2040_CR57","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/0897190019828915","volume":"33","author":"I Fuzaylova","year":"2020","unstructured":"Fuzaylova\u00a0I, Lam\u00a0C, Talreja\u00a0O, Makaryus\u00a0AN, Ahern\u00a0D, Cassagnol\u00a0M. Sacubitril\/valsartan (Entresto\u00ae)-induced hyponatremia. J\u00a0Pharm Pract. 2020;33:696\u20139.","journal-title":"J Pharm Pract"},{"key":"2040_CR58","unstructured":"Theis SR, Khandhar PB. Pseudohyponatremia. Treasure Island (FL): StatPearls Publishing. 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553207\/. Accessed 5 Aug 2021."},{"key":"2040_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/eurjhf\/hfs174","volume":"15","author":"N Waldr\u00e9us","year":"2013","unstructured":"Waldr\u00e9us\u00a0N, Hahn\u00a0RG, Jaarsma\u00a0T. Thirst in heart failure: a\u00a0systematic literature review. Eur J Heart Fail. 2013;15:141\u20139.","journal-title":"Eur J Heart Fail"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-022-02040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-022-02040-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-022-02040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T11:02:39Z","timestamp":1663671759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-022-02040-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":59,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s00508-022-02040-z","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I.\u00a0Velat, \u017d.\u00a0Bu\u0161i\u0107 and V.\u00a0\u010culi\u0107 declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in compliance with the Helsinki Declaration. The study protocol was approved by the Ethics Committee of the University Hospital Center Split (Number 2181-147-01\/06\/M.B.-16-2) and informed consent was obtained from each patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}